About GASD
GASD is a company based in Koln (Germany) founded in 1991 was acquired by Ergomed in June 2016. GASD operates in a competitive market with competitors including Charles River Laboratories, LabCorp, Cytel, Precision Medicine Group and Veeda Clinical Research, among others.
Investors in GASD
GASD has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Ergomed.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Clinical CRO services for oncology and rare diseases are provided. | 1997 | ergomedplc.com | Guildford, United Kingdom |
Investor details for GASD
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of GASD
2 dated milestones of GASD across 25 years, from founding to its latest funding, stage changes and deals.
- Founded GASD is founded.
- Exit Acquired by Ergomed.
Competitors of GASD
GASD operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Charles River Laboratories, LabCorp, Cytel, Precision Medicine Group and Veeda Clinical Research, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| criver.com | 1947 | Wilmington, United States | – | 21,400 | Provider of drug discovery and preclinical development services | |
| labcorp.com | 1969 | Burlington, United States | – | 9,321 | Provider of laboratory tests for physicians | |
| cytel.com | 1987 | Cambridge, United States | $2M | 509 | Data analysis and statistical solutions are provided for life sciences. | |
| precisionmedicinegrp.com | 2012 | Bethesda, United States | $257.21M | 2,151 | Provider of clinical research, development, and commercialization services for life sciences | |
| veedacr.com | 2004 | Ahmedabad, India | – | – | Drug development services encompassing clinical trials, bioanalytical support, and real-world evidence in healthcare. | |
| precisionformedicine.com | 2013 | Bethesda, United States | $150M | – | Company offering specialised R&D and clinical development services for the development of precision medicine based drugs and devices | |
| covance.com | 1996 | Princeton, United States | – | – | CRO offering comprehensive drug development solutions from drug discovery to life cycle management | |
| qps.com | 1995 | Newark, United States | – | – | Contract research organisation offering drug discovery, preclinical and clinical development services | |
| frontagelab.com | 2001 | Exton, United States | $10.24M | – | Early drug development services are provided for pharma firms. | |
| canopybiosciences.com | 2016 | St. Louis, United States | $4.48M | – | Cell line engineering services are offered via CRISPR-Cas9 technology. |
Detailed competitors of GASD
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to GASD
10 companies that operate in the same segment as GASD (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about GASD
GASD was founded in 1991.
GASD is headquartered in Koln, Germany. It is registered at Koln, North Rhine-westphalia, Germany.
GASD was founded in 1991 in Cologne, Germany, where operations are based. Services in statistics and data management are offered to contract research organizations (CROs) within the pharmaceutical and research sectors. Core activities include data processing, statistical analysis, and support for clinical trials. The company focuses on reliable data handling to meet regulatory standards, serving clients across Europe from its German headquarters.
GASD's top competitors include LabCorp, Charles River Laboratories and Cytel.
GASD has 1 investor. Key investors include Ergomed.
Yes. GASD was acquired by Ergomed in June 2016.